Validation of the Arabic Version of the Movement Disorder Society-Unified Parkinson's Disease Rating Scale.

Journal: Movement disorders : official journal of the Movement Disorder Society

Volume: 37

Issue: 4

Year of Publication: 2022

Affiliated Institutions:  Department of Physical Therapy and Rehabilitation Sciences, College of Health Sciences, QU Health, Qatar University, Doha, Qatar. Neurology Unit, King Fahad Medical Military Complex, Dhahran, Saudi Arabia. Department of Physiotherapy, School of Rehabilitation Sciences, University of Jordan, Amman, Jordan. Faculty of Applied Medical Sciences, Department of Rehabilitation Sciences, Jordan University of Science and Technology, Irbid, Jordan. National Neuroscience Nursing Administration, Executive Administration of Nursing Affairs, Riyadh, Saudi Arabia. University of Texas Health Science Center at Houston - McGovern Medical School, Houston, Texas, USA. Neurology Department, Kasr Al-Ainy School of Medicine, Cairo University, Cairo, Egypt. Department of Neurology, Clinical Investigation Center - Razi University Hospital, Faculté de Médecine de Tunis, Université Tunis El Manar, Tunis, Tunisia. Neurology department, Beni-Suef University, Egypt. Neurology Division, Al-Adan Hospital, Kuwait City, Kuwait. Clinical Neuroscience Department, Salmaniya Medical Complex, Manama, Bahrain. Neurology Department, Rashid Hospital, Dubai, UAE. Neurology Department, Hadassah Hospital, Jerusalem, Israel. Department of Neurology, Clinical Investigation Center - Habib Bourguiba Hospital University Center, Sfax, Tunisia. Cell Therapy Center, University of Jordan, Amman, Jordan. Department of Neurology, Faculty of Medicine, Alexandria University, Alexandria, Egypt. Department of Neurology, Zagazig University, Zagazig, Egypt. Neuroscience Centre, King Fahd Specialist Hospital, Dammam, Saudi Arabia. Neurology Department- Ibn Sina Hospital, Kuwait City, Kuwait. Department of Neurology, Clinical Investigation Center - Razi Hospital, Faculté de Médecine de Tunis, Tunis El Manar University, Tunis, Tunisia. Department of Neurology, P. J. Safarik University, Kosice, Kosice, Slovak Republic. Department of Biostatistics and Data Science, The University of Texas Health Science Center at Houston, Houston, Texas, USA. Center for Networked Biomedical Research in Neurodegenerative Diseases (CIBERNED), Carlos III Institute of Health, Madrid, Spain. Department of Neurological Sciences, Rush University Medical Center, Chicago, Illinois, USA. Department of Biostatistics and Bioinformatics, Duke University, Durham, North Carolina, USA. Department of Neurology, National Neuroscience Institute, King Fahad Medical City, Riyadh, Saudi Arabia.

Abstract summary 

The Movement Disorder Society-Unified Parkinson's Disease Rating Scale (MDS-UPDRS) has become the gold standard for evaluating different domains in Parkinson's disease (PD), and it is commonly used in clinical practice, research, and clinical trials.The objectives are to validate the Arabic-translated version of the MDS-UPDRS and to assess its factor structure compared with the English version.The study was carried out in three phases: first, the English version of the MDS-UPDRS was translated into Arabic and subsequently back-translated into English by independent translation team; second, cognitive pretesting of selected items was performed; third, the Arabic version was tested in over 400 native Arabic-speaking PD patients. The psychometric properties of the translated version were analyzed using confirmatory factor analysis (CFA) as well as exploratory factor analysis (EFA).The factor structure of the Arabic version was consistent with that of the English version based on the high CFIs for all four parts of the MDS-UPDRS in the CFA (CFI ≥0.90), confirming its suitability for use in Arabic.The Arabic version of the MDS-UPDRS has good construct validity in Arabic-speaking patients with PD and has been thereby designated as an official MDS-UPDRS version. The data collection methodology among Arabic-speaking countries across two continents of Asia and Africa provides a roadmap for validating additional MDS rating scale initiatives and is strong evidence that underserved regions can be energically mobilized to promote efforts that apply to better clinical care, education, and research for PD. © 2022 International Parkinson and Movement Disorder Society.

Authors & Co-authors:  Khalil Hanan H Aldaajani Zakiyah F ZF Aldughmi Mayis M Al-Sharman Alham A Mohammad Tareq T Mehanna Raja R El-Jaafary Shaimaa I SI Dahshan Ahmed A Ben Djebara Mouna M Kamel Walaa A WA Amer Hanan A HA Farghal Mohammed M Abdulla Fatema F Al-Talai Nouf N Snineh Muneer Abu MA Farhat Nouha N Jamali Fatima A FA Matar Rawan K RK Abdelraheem Heba S HS Ghonimi Nesma A M NAM Al-Melh Mishal Abu MA Elbhrawy Sonia S Alotaibi Majid S MS Elaidy Shaimaa A SA Almuammar Shahad A SA Al-Hashel Jasem Y JY Gouider Riadh R Samir Hatem H Mhiri Chokri C Skorvanek Matej M Lin Jeffrey J Martinez-Martin Pablo P Stebbins Glenn T GT Luo Sheng S Goetz Christopher G CG Bajwa Jawad A JA

Study Outcome 

Source Link: Visit source

Statistics
Citations :  Martinez-Martin P, Rodriguez-Blazquez C, Alvarez-Sanchez M, Arakaki T, Bergareche-Yarza A, Chade A, et al. Expanded and independent validation of the Movement Disorder Society-Unified Parkinson's disease rating scale (MDS-UPDRS). J Neurol 2013;260(1):228-236.
Authors :  36
Identifiers
Doi : 10.1002/mds.28905
SSN : 1531-8257
Study Population
Male,Female
Mesh Terms
Factor Analysis, Statistical
Other Terms
Parkinson's disease;rating scale;validation
Study Design
Exploratory Study,Cross Sectional Study
Study Approach
Country of Study
Publication Country
United States